THERAPEUTIC MANUFACTURING SHARED RESOURCE (TMSR) The Fred Hutch/University of Washington Cancer Consortium, a world leader in the detection, diagnosis, and prevention of cancer, has built a state-of-the-art clinical manufacturing center of excellence within the Therapeutic Manufacturing Shared Resource (TMSR), located at Fred Hutch (FH). This resource provides translational services that enable complex cancer research treatments to progress from the lab to the bedside. TMSR provides clinical manufacturing services for a multitude of products for Consortium investigators that span from traditional biologics to advanced cell and gene therapy applications. Utilizing the TMSR, Consortium members have initiated a range of Phase I and II clinical trials that have advanced the scientific understanding of cancer therapies. The services provided by TMSR follow current Good Manufacturing Practices (cGMP) and include personnel that are highly trained in the field of clinical manufacturing. Additionally, the facilities and equipment are maintained in a qualified cGMP manner and all products are subject to quality control testing and quality assurance systems that ensure the safe manufacture and release of clinical trial materials. The TMSR also provides project management and process development resources to both improve manufacturing success rates and help to translate projects from faculty labs into the cGMP manufacturing facility efficiently and effectively. Taken together, these services are critical for Consortium member who wish to quickly and safety translate with research directly into the clinic in order to conduct Phase I and II clinical studies in a cost- effective, compliant, and timely manner for complex cell and gene therapy modalities. The TMSR effectively consolidates the development and production of highly complex biological and ?living? cellular and gene therapies into a single, shared resource. The TMSR ensures FDA compliance and provides regulatory support that enables the translation of potential therapeutic products from the benchtop to the bedside thereby providing direct impact on patient outcomes.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Fred Hutchinson Cancer Research Center
United States
Zip Code
Kuzma, Jessica N; Cromer, Gail; Hagman, Derek K et al. (2018) Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr :
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Puré, Ellen; Hingorani, Sunil R (2018) Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy. Trends Cancer 4:273-277
Yu, Hsiang; Cheng, Yu-Jen; Wang, Ching-Yun (2018) Methods for multivariate recurrent event data with measurement error and informative censoring. Biometrics 74:966-976
Linden, Hannah M; Peterson, Lanell M; Fowler, Amy M (2018) Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 13:415-422
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005
Winters, Brian R; Vakar-Lopez, Funda; Brown, Lisha et al. (2018) Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy. Urol Oncol 36:342.e7-342.e14
Molina, Yamile; Briant, Katherine J; Sanchez, Janeth I et al. (2018) Knowledge and social engagement change in intention to be screened for colorectal cancer. Ethn Health 23:461-479
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843

Showing the most recent 10 out of 1267 publications